Advertisement
News
Advertisement

New Haven Pharma gets $6M, prepares for approval

Mon, 10/29/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

New Haven Pharmaceuticals Inc. (NHP), which plans to seek approval for a slow-release aspirin product next year, has received a $6.6 million Series A round from a mix of private and public investment groups.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading